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Abstract
The present study evaluated, whether vaccination against both PCV2 and Lawsonia intracellularis in the same herd could 
be economically beneficial for the farmer and at the same time reduce the antibiotic consumption. The study was carried 
out in a wean-to-finish herd receiving 1000 weaned pigs every 7th week. The herd experienced lowered average daily 
weight gain (ADWG), increased feed conversion rate (FCR), and high mortality in the finishers, and use of group medica-
tion with antibiotics for treatment of clinical disease was frequently neccesary. Based on analysis of blood samples from 
several age groups of pigs, vaccination against PCV2 and ileitis (Lawsonia intracellularis) was initiated. Data for antibi-
otic use and performance was collected for one year before and after vaccination. The data showed that the antibiotic 
consumption, given as daily doses per produced pig, was reduced by 39% in the weaners and by 59% in the finishers. 
In the finishing unit, ADWG was increased with 44 g/day, FCR was reduced with 0.21 feeding units/kg gain, mortality 
was reduced with 1.79%, and antibiotic expenses was reduced with 1.15€/produced pig (p-values ANOVA 0.0133, 
0.0005, <0.0001, and 0.0156). Economic evaluation showed a return on investment of 1:2.5. Thus, vaccination 
against PCV2 and ileitis was economically beneficial and reduced antibiotic consumption significantly.
Introduction
The typical way to evaluate the value of pig vaccinations is to calculate the impact on the gross margin for the producer, 
but other parameters might influence the choice of disease control strategy. In Denmark, reduced use of antibiotics for pigs 
has high political priority, and even though Danish pig producers use a low amount of antibiotics compared to many other 
countries (1), Danish producers experience pressure from the public to reduce this amount. The use of vaccines to prevent 
disease before the pigs need treatment with antibiotics is a way to comply with the political demands, providing that the 
use of vaccines does not lower the gross margin for the producer.
The use of antibiotics are significantly lowered in herds vaccinating against ileitis (2) or PCV2 (3), and vaccination against 
either ileitis (4) or PCV2-virus (5) has proven to be efficient tools to increase performance. This study was designed to 
examine whether vaccination against ileitis and PCV2 in the same herd could significantly reduce the use of antibiotics 
and still be economically beneficial.
Figure 1. Before vaccination: 1-2 pigs per pen started to waste in the end of finishing Materials and methods 
SafePork 2011
342
back to index
P
ro
ceed
in
gs - Po
sters     
Materials and methods 
The study herd was a wean-to-finish herd. The herd received 1000 4 week old SPF weaners every 7th week, and they 
were moved to a finishing unit 7 weeks later. Antibiotics were used only when indicated by the clinical status of the pigs.
The study was a before-after study comparing selected parameters for the herd before and after initiation of vaccinations 
against PCV2 and ileitis. The vaccines were implemented based on clinical observations in the herd (fig. 1) and analy-
ses of blood samples. The analyses showed moderate to high values for PCV2 in PCR analysis and seroconversion for 
Lawsonia intracellularis in the finishing period.
For description of the herd before and after, production parameters and the amount of antibiotics prescribed was 
collected. Efficacy reports was prepared every 7th week after emptying of the nursery, and data for antibiotic prescriptions 
were obtained from the Vetstat database. Vetstat data were collected 1 year before and 1 year after start of vaccination, 
leaving out 2 months as transition period, where both vaccinated and non-vaccinated pigs were present in the barn. 
Comparison of before and after was done with ANOVA (ADWG, FCR and antibiotics) or Fishers Exact test (mortality), 
using p≤0.05 as significance level. Key values from the Danish Pig Producers (6) were used for economical calculations.
Results
The number of daily doses of antimicrobials for vaccinated pigs was reduced with 39% in the weaning unit and with 52% 
in the finishing unit after start of vaccination. Details regarding the choice of antibiotics showed that the reduction mainly 
was seen in oral medication, both in the weaning unit and in the fattening unit. The products used for the finishers before 
and after vaccination is shown in figure 2.
Comparison of performance before and after vaccination showed no differences in the weaning unit, but in the finishing 
unit, a significant improvement was seen regarding ADWG, FCR and mortality (table 1). The development in performance 
of the finishers is illustrated in fig. 3 and 4. The return on investment was 1:2.5, meaning that one € spent on vaccine 
was paid back 2.5 times in improved production and saved antibiotic expences.
*= Values with a significant difference (p≤0.05).
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Figure 1: Antibiotic use in finishers without or with vaccination against PCV2 and ileitis 
The total amount was reduced by 59% in the year before vaccination compared to the year after.
Discussion
A large part of the antibiotics used to treat herds infected with PCV2 and ileitis will be given to all pigs in the herd. This 
was reflected in the results of this study, where the main reduction in the number of daily doses per produced pigs was 
seen in oral medication. However, injections given to individual pigs were also reduced. Though this will affect the overall 
antibiotic use to a lower extent, it is still important to the farmer, because it will reduce the daily workload for identifying 
and treating diseased pigs.
For the production parameters, an error in the feed composition disturbed the calculations. In a short period after the 
transition period, the pigs were fed 13% less protein than expected, and this had a negative influence on the average 
daily gain (ADWG) and the feed conversion rate (FCR) for the first two periods with vaccinated pigs, as seen in figure 
3. Therefore, these two observations were excluded from the statistical calculations regarding these two parameters. The 
mortality was not affected by the erroneous feed composition, but decreased immidiately as a response to vaccination 
against PCV2 and ileitis (fig. 4).
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Figure 3: ADWG and feed conversion rate in finishing unit before and after vaccination against PCV2 and ileitis. Each point on the graph represents 
one efficacy report covering 2000 finishers
Figure 4: Mortality in finishing unit before and after vaccination against PCV2 and ileitis. 
Each point on the graph represents one efficacy report covering 2000 finishers
Conclusion
Vaccination against ileitis and PCV2 in the same herd successfully decreased the need for antibiotic treatment, especially 
regarding oral medications. With this reduced use of antibiotics, the vaccinated pigs grew faster and had a better FCR 
than non-vaccinated pigs getting more antibiotics, thus demonstrating, that prevention (vaccination) is better than cure 
(antibiotics), also from an economical point of view.
Hence, the use of vaccines can help pig producers to maintain a sustainable production system, by improving the gross 
margin per pig at the same time as the use of antibiotics is decreased to meet the increasingly higher demands from 
politicians and consumers.
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